Showing items 1–100
Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex
Grant US-11925676-B2
United States of America
Interleukin-15 based immune cytokines
Application KR-20240024242-A
Republic of Korea
Interleukin 15 variant
Application KR-20240024241-A
Republic of Korea
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
Grant US-11891434-B2
United States of America
Method of treating cancer with composition comprising IL-15-based molecules and BCG
Grant US-11890323-B2
United States of America
Modified-IgG antibodies that bind transforming growth factor-BETA1 with high affinity…
Grant US-11834495-B2
United States of America
Methods for producing antibodies promoting disappearance of antigens having plurality of…
Grant US-11827699-B2
United States of America
Drug containing carrier into cell for forming immune complex
Grant US-11820793-B2
United States of America
Anti-CD94 antibodies and methods of use thereof
Grant US-11795228-B2
United States of America
Composition for prophylaxis or treatment of IL-8 related diseases
Grant US-11780912-B2
United States of America
Anti-Dectin-2 antibodies
Grant US-11753474-B2
United States of America
VACCINE COMPRISING AN ANTIBODY OR AN FC-CONTAINING FUSION PROTEIN COMPRISING AN FC PART…
Application WO-2023166081-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2
Application WO-2023156636-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2
Application EP-4230650-A1
European Patent Office
Anti-SIRP α antibodies
Grant US-11718681-B2
United States of America
Method for altering plasma retention and immunogenicity of antigen-binding molecule
Grant US-11718678-B2
United States of America
Antibody molecules which bind CD45
Grant US-11692041-B2
United States of America
BINDING MOLECULES FOR FCγRIIA AND USE THEREOF
Application WO-2023116770-A1
World Intellectual Property Organisation (WIPO)
IL-15-based molecules and methods of use thereof
Grant US-11679144-B2
United States of America
Fusion molecules and IL-15 variants
Grant US-11673932-B2
United States of America
Anti-lag-3 antibody polypeptide
Grant US-11661452-B2
United States of America
Anti-CD38 antibodies and formulations
Grant US-11655302-B2
United States of America
Bispecific antibodies against CEACAM5 and CD47
Grant US-11555071-B2
United States of America
ENGINEERED POLYPEPTIDES
Application WO-2022251119-A3
World Intellectual Property Organisation (WIPO)
INTERLEUKIN-15 BASED IMMUNOCYTOKINES
Application WO-2022268983-A2
World Intellectual Property Organisation (WIPO)
INTERLEUKIN 15 VARIANTS
Application WO-2022268991-A1
World Intellectual Property Organisation (WIPO)
Fusion molecules and IL-15 variants
Grant US-11498950-B1
United States of America
Anti-IL1RAP antibody
Grant US-11479610-B2
United States of America
IL-15-based molecules and methods of use thereof
Grant US-11471511-B2
United States of America
Antibody molecules which bind CD22
Grant US-11472879-B2
United States of America
Antigen-binding molecule for promoting disappearance of antigen via FcγRIIB
Application KR-20220136441-A
Republic of Korea
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant US-11454633-B2
United States of America
ANTIBODIES
Application WO-2022167815-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES
Application WO-2022167816-A2
World Intellectual Property Organisation (WIPO)
Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer
Grant US-11407840-B2
United States of America
Heterodimeric Fc variants
Grant US-11401348-B2
United States of America
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Grant US-11371039-B2
United States of America
Multimeric IL-15-based molecules
Grant US-11369679-B2
United States of America
Interleukin 15 (IL-15) variants
Grant US-11365231-B2
United States of America
Anti-SARS-COV-2 antibodies and uses thereof
Grant US-11365239-B2
United States of America
ANTIBODY-DRUG CONJUGATES BASED ON HUMANIZED CLDN18.2 ANTIBODIES
Application WO-2022122709-A1
World Intellectual Property Organisation (WIPO)
Anti-myostatin antibodies and methods of use
Grant US-11359009-B2
United States of America
Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
Grant US-11359194-B2
United States of America
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
Grant US-11332538-B2
United States of America
Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity…
Grant US-11325970-B2
United States of America
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and…
Grant US-11325971-B2
United States of America
Multimeric IL-15-based molecules
Grant US-11318201-B2
United States of America
BINDING MOLECULES THAT MULTIMERISE CD45
Application WO-2022079199-A1
World Intellectual Property Organisation (WIPO)
Multispecific antibodies
Grant US-11286312-B2
United States of America
Anti-SIRPα antibodies
Grant US-11274159-B2
United States of America
Fc region variant
Grant US-11267868-B2
United States of America
Molecules with specificity for CD79 and CD22
Grant US-11261252-B2
United States of America
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant US-11248053-B2
United States of America
Antibodies against MICA and/or MICB and uses thereof
Grant US-11242393-B2
United States of America
Methods of producing an IL-1 RAP antibodies
Grant US-11236172-B2
United States of America
Mouse FcγammaRII-specific Fc antibody
Grant US-11236168-B2
United States of America
Fc variants
Grant US-11198732-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-11198739-B2
United States of America
Methods of neutralizing IL-8 biological activity
Grant US-11180548-B2
United States of America
IL-15-based molecules and methods of use thereof
Grant US-11173191-B2
United States of America
Antigen-binding molecule containing modified Fc region
Grant US-11142563-B2
United States of America
Heteromultimers with reduced or silenced effector function
Grant US-11098105-B2
United States of America
Method for treating IL-8-related diseases
Grant US-11053308-B2
United States of America
Superkine
Grant US-11053299-B2
United States of America
ANTI-CTLA-4 ANTIBODY AND USE THEREOF
Application WO-2021131021-A1
World Intellectual Property Organisation (WIPO)
TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODIES
Application WO-2021130291-A1
World Intellectual Property Organisation (WIPO)
Methods for controlling blood pharmacokinetics of antibodies
Grant US-11046784-B2
United States of America
HUMANIZED CLDN18.2 ANTIBODIES
Application WO-2021111003-A1
World Intellectual Property Organisation (WIPO)
Method employing bispecific protein complex
Grant US-10954312-B2
United States of America
Antigen-binding molecule for promoting disappearance of antigen via FcγRIIB
Application KR-20210022764-A
Republic of Korea
FcgammaRIIB-specific Fc region variant
Grant US-10919953-B2
United States of America
ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS
Application WO-2021009358-A1
World Intellectual Property Organisation (WIPO)
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
Grant US-10894830-B2
United States of America
ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA FC GAMMA RIIB
Application EP-3738980-A1
European Patent Office
Method employing bispecific antibodies
Grant US-10829566-B2
United States of America
Recombinant bi-functional fusion protein and preparation and application therefor
Grant US-10800821-B2
United States of America
Molecules with specificity for CD45 and CD79
Grant US-10774152-B2
United States of America
Multispecific antibodies
Grant US-10774157-B2
United States of America
Heterodimerized polypeptide
Grant US-10766960-B2
United States of America
Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
Grant US-10752692-B2
United States of America
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant US-10738111-B2
United States of America
ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER
Application WO-2020159504-A1
World Intellectual Property Organisation (WIPO)
HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTION
Application EP-3541837-A4
European Patent Office
NOVEL ANTAGONISTIC ANTI TNFR2 ANTIBODY MOLECULES
Application WO-2020089474-A1
World Intellectual Property Organisation (WIPO)
NOVEL AGONISTIC ANTIBODY MOLECULES
Application WO-2020089473-A2
World Intellectual Property Organisation (WIPO)
Antibody molecules which bind CD79
Grant US-10618957-B2
United States of America
Method for altering plasma retention and immunogenicity of antigen-binding molecule
Grant US-10618965-B2
United States of America
Multispecific antibodies
Grant US-10618979-B2
United States of America
Antibody molecules which bind CD22
Grant US-10590197-B2
United States of America
Method of detection of IL1RAP on cells expressing the protein
Grant US-10562971-B2
United States of America
Nucleic acids encoding IL-8 antibodies
Grant US-10519229-B2
United States of America
ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and…
Grant US-10508146-B2
United States of America
MODULATING ANTIBODY DEPENDENT CELLULAR PHAGOCYTOSIS
Application WO-2019236739-A1
World Intellectual Property Organisation (WIPO)
ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE
Application EP-3390443-A4
European Patent Office
Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
Grant US-10472623-B2
United States of America
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
Grant US-10457737-B2
United States of America
Molecules with specificity for CD79 and CD22
Grant US-10370447-B2
United States of America
Bispecific format suitable for use in high-through-put screening
Grant US-10358493-B2
United States of America
Fc variants with altered binding to FcRn
Grant US-10336818-B2
United States of America
Showing items 1–100